vTv Therapeutics Statistics
Total Valuation
VTVT has a market cap or net worth of $261.29 million. The enterprise value is $184.13 million.
| Market Cap | 261.29M |
| Enterprise Value | 184.13M |
Important Dates
The last earnings date was Thursday, November 5, 2026, after market close.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VTVT has 12.42 million shares outstanding. The number of shares has increased by 78.56% in one year.
| Current Share Class | 3.95M |
| Shares Outstanding | 12.42M |
| Shares Change (YoY) | +78.56% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 0.36% |
| Owned by Institutions (%) | 15.44% |
| Float | 2.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.09 |
| Forward PS | n/a |
| PB Ratio | 3.75 |
| P/TBV Ratio | 3.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.00 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.19, with zero debt.
| Current Ratio | 11.19 |
| Quick Ratio | 10.99 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10,978.00 |
Financial Efficiency
Return on equity (ROE) is -10.95% and return on invested capital (ROIC) is -9.76%.
| Return on Equity (ROE) | -10.95% |
| Return on Assets (ROA) | -7.70% |
| Return on Invested Capital (ROIC) | -9.76% |
| Return on Capital Employed (ROCE) | -15.34% |
| Weighted Average Cost of Capital (WACC) | 5.68% |
| Revenue Per Employee | $1.42M |
| Profits Per Employee | -$295,308 |
| Employee Count | 26 |
| Asset Turnover | 0.41 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.24% in the last 52 weeks. The beta is 0.26, so VTVT's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | -13.24% |
| 50-Day Moving Average | 29.23 |
| 200-Day Moving Average | 33.22 |
| Relative Strength Index (RSI) | 23.13 |
| Average Volume (20 Days) | 20,923 |
Short Selling Information
The latest short interest is 143,400, so 1.15% of the outstanding shares have been sold short.
| Short Interest | 143,400 |
| Short Previous Month | 156,754 |
| Short % of Shares Out | 1.15% |
| Short % of Float | 6.64% |
| Short Ratio (days to cover) | 3.87 |
Income Statement
In the last 12 months, VTVT had revenue of $36.84 million and -$7.68 million in losses. Loss per share was -$0.62.
| Revenue | 36.84M |
| Gross Profit | 18.98M |
| Operating Income | -10.98M |
| Pretax Income | -7.68M |
| Net Income | -7.68M |
| EBITDA | -10.97M |
| EBIT | -10.98M |
| Loss Per Share | -$0.62 |
Balance Sheet
The company has $77.16 million in cash and no debt, with a net cash position of $77.16 million or $6.21 per share.
| Cash & Cash Equivalents | 77.16M |
| Total Debt | n/a |
| Net Cash | 77.16M |
| Net Cash Per Share | $6.21 |
| Equity (Book Value) | 69.69M |
| Book Value Per Share | 5.61 |
| Working Capital | 71.58M |
Cash Flow
| Operating Cash Flow | -16.76M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 5,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -16.76M |
| FCF Per Share | -$1.35 |
Margins
Gross margin is 51.52%, with operating and profit margins of -29.80% and -20.84%.
| Gross Margin | 51.52% |
| Operating Margin | -29.80% |
| Pretax Margin | -20.84% |
| Profit Margin | -20.84% |
| EBITDA Margin | -29.79% |
| EBIT Margin | -29.80% |
| FCF Margin | n/a |
Dividends & Yields
VTVT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -78.56% |
| Shareholder Yield | -78.56% |
| Earnings Yield | -2.94% |
| FCF Yield | -6.42% |
Analyst Forecast
The average price target for VTVT is $55.67, which is 164.72% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $55.67 |
| Price Target Difference | 164.72% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on November 21, 2023. It was a reverse split with a ratio of 1:40.
| Last Split Date | Nov 21, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:40 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |